179 related articles for article (PubMed ID: 31798724)
1. Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.
Bostan M; Petrică-Matei GG; Ion G; Radu N; Mihăilă M; Hainăroşie R; Braşoveanu LI; Roman V; Constantin C; Neagu MT
Exp Ther Med; 2019 Dec; 18(6):5041-5051. PubMed ID: 31798724
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin.
Bostan M; Petrică-Matei GG; Radu N; Hainarosie R; Stefanescu CD; Diaconu CC; Roman V
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32859062
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines.
Bostan M; Mihaila M; Petrica-Matei GG; Radu N; Hainarosie R; Stefanescu CD; Roman V; Diaconu CC
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204834
[TBL] [Abstract][Full Text] [Related]
4. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells.
Seo YS; Yim MJ; Kim BH; Kang KR; Lee SY; Oh JS; You JS; Kim SG; Yu SJ; Lee GJ; Kim DK; Kim CS; Kim JS; Kim JS
Oncol Rep; 2015 Dec; 34(6):3025-34. PubMed ID: 26503508
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.
Lin HY; Sun M; Tang HY; Simone TM; Wu YH; Grandis JR; Cao HJ; Davis PJ; Davis FB
J Cell Biochem; 2008 Aug; 104(6):2131-42. PubMed ID: 18446786
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.
Park MR; Kim SG; Cho IA; Oh D; Kang KR; Lee SY; Moon SM; Cho SS; Yoon G; Kim CS; Oh JS; You JS; Kim DK; Seo YS; Im HJ; Kim JS
Food Chem Toxicol; 2015 Mar; 77():34-43. PubMed ID: 25572524
[TBL] [Abstract][Full Text] [Related]
7. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
Xiao D; Singh SV
Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262
[TBL] [Abstract][Full Text] [Related]
8. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
9. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
11. Quantitative phosphoproteomic analysis reveals γ-bisabolene inducing p53-mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation.
Jou YJ; Chen CJ; Liu YC; Way TD; Lai CH; Hua CH; Wang CY; Huang SH; Kao JY; Lin CW
Proteomics; 2015 Oct; 15(19):3296-309. PubMed ID: 26194454
[TBL] [Abstract][Full Text] [Related]
12. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin.
Persons DL; Yazlovitskaya EM; Pelling JC
J Biol Chem; 2000 Nov; 275(46):35778-85. PubMed ID: 10958792
[TBL] [Abstract][Full Text] [Related]
13. P2Y
Woods LT; Jasmer KJ; Muñoz Forti K; Shanbhag VC; Camden JM; Erb L; Petris MJ; Weisman GA
Oral Oncol; 2020 Jun; 109():104808. PubMed ID: 32540611
[TBL] [Abstract][Full Text] [Related]
14. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.
Liu J; Mao W; Ding B; Liang CS
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1956-65. PubMed ID: 18775851
[TBL] [Abstract][Full Text] [Related]
15. Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment.
Muscella A; Urso L; Calabriso N; Ciccarese A; Migoni D; Fanizzi FP; Di Jeso B; Storelli C; Marsigliante S
Biochem Pharmacol; 2005 Dec; 71(1-2):50-60. PubMed ID: 16297374
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
17. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
Wu J; Tang Q; Zhao S; Zheng F; Wu Y; Tang G; Hahn SS
Int J Oncol; 2014 Jul; 45(1):95-103. PubMed ID: 24806432
[TBL] [Abstract][Full Text] [Related]
19. Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1.
Liu CH; Chen CY; Huang AM; Li JH
J Ethnopharmacol; 2011 Sep; 137(1):503-11. PubMed ID: 21708241
[TBL] [Abstract][Full Text] [Related]
20. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.
Albanell J; Codony-Servat J; Rojo F; Del Campo JM; Sauleda S; Anido J; Raspall G; Giralt J; Roselló J; Nicholson RI; Mendelsohn J; Baselga J
Cancer Res; 2001 Sep; 61(17):6500-10. PubMed ID: 11522647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
